 <h1>MICRhoGAM Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>rho (d) immune globulin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about rho (d) immune globulin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name MICRhoGAM.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to rho (d) immune globulin: solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intravenous route (Powder for Solution; Solution)</p><p>Intravascular hemolysis (IVH) leading to death has been reported in patients treated for immune thrombocytopenic purpura (ITP) with Rho(D) immune globulin. IVH can lead to clinically compromising anemia and multi-system organ failure, including acute respiratory distress syndrome (ARDS), acute renal insufficiency, renal failure, and disseminated intravascular coagulation (DIC). Alert patients and closely monitor for the signs and symptoms of IVH in a health care setting for at least 8 hours after administration for ITP. Perform a dipstick urinalysis at baseline, 2 hours, 4 hours after administration, and prior to the end of the monitoring period. If signs and/or symptoms of IVH are present or suspected, post-treatment laboratory tests should be performed.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, rho (d) immune globulin (the active ingredient contained in MICRhoGAM) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking rho (d) immune globulin:</p><p>
<i>Rare</i>
</p><ul>
<li>Bloody urine</li>
<li>decreased frequency of urination or amount of urine</li>
<li>fever</li>
<li>increased blood pressure</li>
<li>increased thirst</li>
<li>loss of appetite</li>
<li>lower back pain</li>
<li>nausea or vomiting</li>
<li>pale skin</li>
<li>swelling of the face, fingers, or lower legs</li>
<li>troubled breathing</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>weight gain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of rho (d) immune globulin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Soreness at the place of injection</li>
</ul><p>
<!-- end solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rho (d) immune globulin: injectable powder for injection, injectable solution, intramuscular powder for injection, intramuscular solution</i></p><h3>Other</h3><p><b>Very common</b> (10% or more): Chills (34.7%), pyrexia/increased body temperature (32.6%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Malaise</p>
<p><b>Very rare</b> (less than 0.01%): Death</p>
<p><b>Frequency not reported</b>: Shivering, weakness</p>
<p><b>Postmarketing reports</b>: Chest pain, fatigue, edema<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hemolytic reaction includes hypotension, nausea, chills, headache, and a decrease in haptoglobin and hemoglobin.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Disseminated intravascular coagulation</p>
<p><b>Frequency not reported</b>: Intravascular hemolysis, hemolysis resulting in death, clinically compromising anemia, extravascular hemolysis, hemolytic reaction</p>
<p><b>Postmarketing reports</b>: Hemoglobinemia, disseminated intravascular coagulation<sup>[Ref]</sup></p><h3>Local</h3><p><b>Uncommon</b> (0.1% to 1%): Injection site swelling, injection site pain</p>
<p><b>Rare</b> (less than 0.1%): Injection site erythema, injection site induration, injection site warmth, injection site pruritus, injection site rash<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (14.3%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Dizziness, vertigo<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Uncommon</b> (0.1% to 1%): Nausea, vomiting</p>
<p><b>Rare</b> (less than 0.1%): Diarrhea<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Rare</b> (less than 0.1%): Tachycardia, hypotension</p>
<p><b>Frequency not reported</b>: Increase in blood pressure</p>
<p><b>Postmarketing reports</b>: Cardiac arrest, cardiac failure, myocardial infarction<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Skin reaction, erythema, pruritus, pallor, rash </p>
<p><b>Postmarketing reports</b>: Hyperhidrosis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Arthralgia, back pain</p>
<p><b>Postmarketing reports</b>: Myalgia, muscle spasm, pain in extremities<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Increase in blood bilirubin (21.4%)</p>
<p><b>Postmarketing reports</b>: Jaundice<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity, anaphylactic shock, anaphylactic reaction<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse events were chills, pyrexia, increased bilirubin, and headache.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (less than 0.1%): Dyspnea</p>
<p><b>Postmarketing reports</b>: Acute respiratory distress syndrome, transfusion related acute lung injury<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Acute renal insufficiency</p>
<p><b>Postmarketing reports</b>: Renal failure, renal impairment<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Transient positive anti-C antibody test</p>
<p><b>Frequency not reported</b>: Sensitization to repeated injections of human globulin<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Postmarketing reports</b>: Hemoglobinuria, anuria, chromaturia, hematuria<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. RhoGAM Ultra-Filtered Plus (RHo (D) immune globulin)." Kedrion Biopharma Inc, Cambridge, MA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. WinRho SDF (RHo (D) immune globulin)." Nabi, Boca Raton, FL. </p><p id="ref_5">5. "Product Information. Rhophylac (RHo (D) immune globulin)." ZLB Bioplasma Inc, Glendale, CA. </p><p id="ref_6">6. "Product Information. HyperRHO S/D Full Dose (RHo (D) immune globulin)." Talecris Biotherapeutics, Research Triangle Park, NC. </p><p id="ref_7">7. "Product Information. BayRHo-D (RHo (D) immune globulin)." Bayer, West Haven, CT. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about MICRhoGAM (rho (d) immune globulin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: immune globulins</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>RhoGAM, RhoGAM Ultra-Filtered Plus, Rhophylac, BayRHo-D, ... +3 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>MicRhoGAM Ultra-Filtered Plus</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Idiopathic Thrombocytopenic Purpura</li>
<li>Rh-Isoimmunization</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rho (d) immune globulin: injectable powder for injection, injectable solution, intramuscular powder for injection, intramuscular solution</i></p><h3>Other</h3><p><b>Very common</b> (10% or more): Chills (34.7%), pyrexia/increased body temperature (32.6%)</p><p><b>Uncommon</b> (0.1% to 1%): Malaise</p><p><b>Very rare</b> (less than 0.01%): Death</p><p><b>Frequency not reported</b>: Shivering, weakness</p><p><b>Postmarketing reports</b>: Chest pain, fatigue, edema<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hemolytic reaction includes hypotension, nausea, chills, headache, and a decrease in haptoglobin and hemoglobin.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Disseminated intravascular coagulation</p><p><b>Frequency not reported</b>: Intravascular hemolysis, hemolysis resulting in death, clinically compromising anemia, extravascular hemolysis, hemolytic reaction</p><p><b>Postmarketing reports</b>: Hemoglobinemia, disseminated intravascular coagulation<sup>[Ref]</sup></p><h3>Local</h3><p><b>Uncommon</b> (0.1% to 1%): Injection site swelling, injection site pain</p><p><b>Rare</b> (less than 0.1%): Injection site erythema, injection site induration, injection site warmth, injection site pruritus, injection site rash<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (14.3%)</p><p><b>Uncommon</b> (0.1% to 1%): Dizziness, vertigo<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Uncommon</b> (0.1% to 1%): Nausea, vomiting</p><p><b>Rare</b> (less than 0.1%): Diarrhea<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Rare</b> (less than 0.1%): Tachycardia, hypotension</p><p><b>Frequency not reported</b>: Increase in blood pressure</p><p><b>Postmarketing reports</b>: Cardiac arrest, cardiac failure, myocardial infarction<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Skin reaction, erythema, pruritus, pallor, rash </p><p><b>Postmarketing reports</b>: Hyperhidrosis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Arthralgia, back pain</p><p><b>Postmarketing reports</b>: Myalgia, muscle spasm, pain in extremities<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Increase in blood bilirubin (21.4%)</p><p><b>Postmarketing reports</b>: Jaundice<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity, anaphylactic shock, anaphylactic reaction<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse events were chills, pyrexia, increased bilirubin, and headache.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (less than 0.1%): Dyspnea</p><p><b>Postmarketing reports</b>: Acute respiratory distress syndrome, transfusion related acute lung injury<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Acute renal insufficiency</p><p><b>Postmarketing reports</b>: Renal failure, renal impairment<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Transient positive anti-C antibody test</p><p><b>Frequency not reported</b>: Sensitization to repeated injections of human globulin<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Postmarketing reports</b>: Hemoglobinuria, anuria, chromaturia, hematuria<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. RhoGAM Ultra-Filtered Plus (RHo (D) immune globulin)." Kedrion Biopharma Inc, Cambridge, MA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. WinRho SDF (RHo (D) immune globulin)." Nabi, Boca Raton, FL. </p><p id="ref_5">5. "Product Information. Rhophylac (RHo (D) immune globulin)." ZLB Bioplasma Inc, Glendale, CA. </p><p id="ref_6">6. "Product Information. HyperRHO S/D Full Dose (RHo (D) immune globulin)." Talecris Biotherapeutics, Research Triangle Park, NC. </p><p id="ref_7">7. "Product Information. BayRHo-D (RHo (D) immune globulin)." Bayer, West Haven, CT. </p><h2>More about MICRhoGAM (rho (d) immune globulin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: immune globulins</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>MicRhoGAM Ultra-Filtered Plus</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Idiopathic Thrombocytopenic Purpura</li>
<li>Rh-Isoimmunization</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>